Evidence map›Paper›PMID 35890191›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole.

Ju-Hyun Lee, Chulhun Park, In-Ok Song, Beom-Jin Lee, Chin-Yang Kang, Jun-Bom Park

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Special Issue for "3D Printing of Drug Formulations".Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Review
  13. 3D printing of pharmaceuticals for disease treatment.Frontiers in medical technology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ju-Hyun LeeCollege of Pharmacy, Sahmyook University, Seoul 01795, Korea.
Chulhun ParkCollege of Pharmacy, Jeju National University, Jeju 63243, Korea.ORCID 0000-0003-4951-3213
In-Ok SongCollege of Pharmacy, Sahmyook University, Seoul 01795, Korea.
Beom-Jin LeeCollege of Pharmacy, Ajou University, Suwon 16499, Korea.ORCID 0000-0003-0922-3289
Chin-Yang KangCollege of Pharmacy, Sahmyook University, Seoul 01795, Korea.
Jun-Bom ParkCollege of Pharmacy, Sahmyook University, Seoul 01795, Korea.ORCID 0000-0001-6193-0023

Funding

This study was supported by the Academic Research Fund of Dr. Myung Ki (Mike) Hong, 2021. Dr. Myung Ki (Mike) Hong, 2021
6 · The paper itself

Abstract

The objective of this study was to design and evaluate an orodispersible film (ODF) composed of aripiprazole (ARP), prepared using a conventional solvent casting technique, and to fuse a three-dimensional (3D) printing technique with a hot-melt extrusion (HME) filament. Klucel

Indexed as

3D printingaripiprazolehot-melt extrusionorodispersible filmpatient-centric drug deliverypuncture strength

Identifiers

PMID35890191
PMCPMC9319750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.